Sii Investments Inc. WI cut its position in Thermo Fisher Scientific Inc (NYSE:TMO) by 30.9% during the first quarter, Holdings Channel reports. The institutional investor owned 2,952 shares of the medical research company’s stock after selling 1,320 shares during the period. Sii Investments Inc. WI’s holdings in Thermo Fisher Scientific were worth $456,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of TMO. Independent Portfolio Consultants Inc. raised its position in Thermo Fisher Scientific by 0.3% in the first quarter. Independent Portfolio Consultants Inc. now owns 730 shares of the medical research company’s stock worth $112,000 after buying an additional 2 shares in the last quarter. Sharkey Howes & Javer raised its position in Thermo Fisher Scientific by 1.0% in the first quarter. Sharkey Howes & Javer now owns 733 shares of the medical research company’s stock worth $113,000 after buying an additional 7 shares in the last quarter. Washington Trust Bank raised its position in Thermo Fisher Scientific by 0.5% in the first quarter. Washington Trust Bank now owns 2,210 shares of the medical research company’s stock worth $339,000 after buying an additional 10 shares in the last quarter. Beacon Trust Co. raised its position in Thermo Fisher Scientific by 0.6% in the first quarter. Beacon Trust Co. now owns 2,159 shares of the medical research company’s stock worth $341,000 after buying an additional 12 shares in the last quarter. Finally, Dumont & Blake Investment Advisors LLC raised its position in Thermo Fisher Scientific by 0.3% in the first quarter. Dumont & Blake Investment Advisors LLC now owns 5,526 shares of the medical research company’s stock worth $849,000 after buying an additional 15 shares in the last quarter. 87.15% of the stock is currently owned by institutional investors.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) traded up 0.86% during midday trading on Friday, reaching $173.21. The company’s stock had a trading volume of 454,571 shares. The company’s 50-day moving average price is $176.85 and its 200 day moving average price is $165.24. The company has a market capitalization of $67.57 billion, a P/E ratio of 30.18 and a beta of 1.06. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $182.87.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The business had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.92 billion. During the same quarter last year, the business posted $2.03 EPS. The business’s revenue was up 10.2% on a year-over-year basis. On average, equities research analysts forecast that Thermo Fisher Scientific Inc will post $9.24 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.35%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is currently 10.45%.

TRADEMARK VIOLATION NOTICE: This piece of content was originally posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark laws. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/thermo-fisher-scientific-inc-nysetmo-stake-lowered-by-sii-investments-inc-wi/1475592.html.

A number of research firms recently commented on TMO. Deutsche Bank AG set a $200.00 price objective on Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Saturday, June 10th. Jefferies Group LLC lifted their price objective on Thermo Fisher Scientific from $160.00 to $175.00 and gave the stock a “hold” rating in a research note on Friday, April 28th. Wells Fargo & Company reaffirmed an “outperform” rating and issued a $200.00 price objective (up from $195.00) on shares of Thermo Fisher Scientific in a research note on Thursday, July 13th. Cleveland Research raised Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research note on Thursday, July 20th. Finally, Bank of America Corporation reaffirmed a “buy” rating and issued a $210.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a research note on Friday, July 21st. One equities research analyst has rated the stock with a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $188.56.

In other news, CFO Stephen Williamson sold 2,500 shares of the firm’s stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $176.26, for a total value of $440,650.00. Following the completion of the transaction, the chief financial officer now owns 37,790 shares in the company, valued at approximately $6,660,865.40. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Marc N. Casper sold 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $172.79, for a total value of $3,455,800.00. Following the completion of the transaction, the chief executive officer now owns 269,279 shares of the company’s stock, valued at approximately $46,528,718.41. The disclosure for this sale can be found here. In the last quarter, insiders sold 27,188 shares of company stock valued at $4,702,223. Company insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.